Android app Apple app link

Beam Therapeutics Earns Relative Strength Rating Upgrade; Hits Key Threshold

By Investor's Business Daily   |   1 month ago
Beam Therapeutics Earns Relative Strength Rating Upgrade; Hits Key Threshold

Discover top growth stocks with the IBD Screen of the Day, which rates market leadership by comparing a stock's price movement over 52 weeks. Best-performing stocks often have an 80 or higher RS Rating. Beam Therapeutics is trading near a buy point after a breakout.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.